$TXTM Mr. Duffield concluded, "The anticipated pos

$TXTM Mr. Duffield concluded, "The anticipated positive outcome of this investigation will enable Protext to enter the wellness market with structure function claims in advance of seeking an FDA clearance specific to diabetes. What this means is that the Company could immediately enter the market as a nutraceutical with claims specific to green tea, such as reducing cholesterol, managing glucose levels, etc. Making claims specific for treating diabetes will most likely require additional trials and further FDA clearance. The current global market size for green tea polyphenols is around $300 million. We believe Phytofare® can become the go-to green tea supplement based on its clinically proven twelve-times greater bioavailability. Our goal is to educate consumers to the significant benefits Phytofare® has over traditional green tea and extracts, which we believe will be further validated through our upcoming clinical research."

Copies of the cited studies on green tea and diabetes will be posted to the company's website. Investors are encouraged to follow Protext using:

YouTube: http://bit.ly/ProtextYouTube
Twitter: https://twitter.com/protxtm
Instagram: https://www.instagram.com/protextm/

https://finance.yahoo.com/news/protext-pharma...58561.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!